Showing results (1-10 of 145) with videos related to
Sort By:
Pageof 15
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2010
Zoom-in array comparative genomic hybridization (aCGH) to detect germline rearrangements in cancer susceptibility genesJohan Staaf, Ake BorgBMC Cancer|March 17, 2006
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectumAnna Isinger, Misha Bhat, Ake Borg, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 2, 2005
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumorsMervi Laakso, Niklas Loman, Ake Borg, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 9, 2006
Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 familiesHelena Jernström, Gunilla Sellberg, Ake Borg, et al.Breast Cancer Research : BCR|October 1, 2008
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancerKatja Lundgren, Karolina Holm, Bo Nordenskjöld, et al.Advances in Cancer Research|March 9, 2002
Gene expression in inherited breast cancerIngrid A Hedenfalk, Markus Ringnér, Jeffrey M Trent, et al.Breast Cancer Research : BCR|October 29, 2003
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation statusNiklas Loman, Anna Bladström, Oskar Johannsson, et al.Breast Cancer Research : BCR|December 16, 2011
Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancerJohan Staaf, Göran Jönsson, Markus Ringnér, et al.European Journal of Cancer (Oxford, England : 1990)|August 25, 2005
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testingHelena Jernström, Niklas Loman, Oskar T Johannsson, et al.Familial Cancer|September 5, 2009
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancerAnna Isinger Ekstrand, Mats Jönsson, Annika Lindblom, et al.Pageof 15